Anthropic is launching an internal drug discovery program with a focus on neglected diseases that traditional pharmaceutical companies would not consider commercially attractive, CNBC reported June 30 ...

Anthropic will start a drug discovery program focused on "neglected" diseases. The artificial intelligence company announced the effort alongside the announcement of Claude Science, a product designed ...

Many venture capitalists contend that AI is set to turbocharge drug discovery. Jim Healy isn’t one of them. Healy is managing partner of Sofinnova Investments, which formed in 1976 and helped birth ...

June 29 (Reuters) – BioCryst Pharmaceuticals said on Monday it would wind down its internal drug discovery programs and close its Alabama research facility by the end of 2026, ‌as it pivots to ...

Our patented cell-free approach now adds a second biosolution to our pipeline and creates new opportunities for pharmaceutical partners.” — Michael Heltzen, CEO of eXoZymes Inc. LOS ANGELES, CA, ...

Creative Diagnostics announces a specialized suite of Respiratory Syncytial Virus Animal Model services. NEW YORK, NY, UNITED STATES, June 25, 2026 /EINPresswire.com ...

June 24 (Reuters) – Antares Therapeutics said on Wednesday it entered a collaboration with Novartis that could be worth up to about $1.9 billion, aiming to develop therapies ‌for historically ...

When Rep. Haley Stevens, D-Mich., launched her Senate campaign last year, she repeatedly villainized Elon Musk, the tech mogul whose cost-cutting government efficiency project was at the time an ...

Developing new medicines can require thousands of chemistry experiments to identify the right recipe for a safe, effective and ideally affordable drug. The process is slow and labor-intensive, and ...

As a launch engineer at SpaceX, Konnor Getz ’25 credits Stevens for preparing him — academically and professionally — for his career. “Through Stevens’ Co-op Program, I gained valuable hands-on ...